253867-12-8

Basic information

• Product Name: Heptanal, 7-(4-fluorophenoxy)-6-hydroxy-, (6S)-
• CAS NO: 253867-12-8
• Molecular Formula: C13H17FO3
• Molecular Weight: 240.275
• Mol File: 253867-12-8.mol

Chemical Properties

• CAS DataBase Reference: Heptanal, 7-(4-fluorophenoxy)-6-hydroxy-, (6S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Heptanal, 7-(4-fluorophenoxy)-6-hydroxy-, (6S)-(253867-12-8)
• EPA Substance Registry System: Heptanal, 7-(4-fluorophenoxy)-6-hydroxy-, (6S)-(253867-12-8)

Safety Data

• Hazardous Substances Data: 253867-12-8(Hazardous Substances Data)

Upstream product

• 253867-11-7 (S)-7-(4-fluorophenoxy)heptan-1,6-diol 
• 253867-10-6 (S)-7-benzyloxy-1-(4-fluorophenoxy)heptan-2-ol 
• 88-67-5 2-Iodobenzoic acid 
• 104605-98-3 (2S)-2-[(4-fluorophenoxy)methyl]oxirane 

Downstream Products

• 253867-13-9 (7S)-2-(benzenesulfonyl)-7-(4-fluorophenoxymethyl)oxepane 
• 253867-14-0 (2S,7S)-7-(4-fluorophenoxymethyl)-2-(1-hydroxy-3-butyn-4-yl)oxepane 
• 850453-95-1 (2S,7S)-7-(4-fluorophenoxymethyl)-2-[N,O-bis(phenoxycarbonyl)-3-butyn-4-yl]oxepane 

Relevant articles and documents

Stereoselective synthesis of (2S,7S)-7-(4-phenoxymethyl)-2-(1-N- hydroxyureidyl-3-butyn-4-yl)oxepane: A potential anti-asthmatic drug candidate

We have achieved a short, efficient stereoselective synthesis of 7-membered oxepane derivatives with potential against asthma. Highlights of our synthetic strategy are regioselective oxidation of a hydroxyl group and efficient ring closure of an open chai

Substituted oxygen alicyclic compounds, including methods for synthesis thereof

The invention provides new methods for preparation of cyclic oxygen compounds, including 2,5-disubstituted tetahydrofurans, 2,6-disubstituted tetrahydropyrans, 2,7-disubstituted oxepanes and 2,8-oxocanes. The invention also provides new cyclic oxygen compounds and pharmaceutical compositions and therapeutic methods that comprise such compounds.